IPSWICH, Mass., March 21, 2013 /PRNewswire/ -- New England Biolabs (NEB), a world leader in the production of reagents for the life science industry, extended its global subsidiary network with the opening of New England Biolabs Pte. Ltd., in Singapore.
"The Singapore facility will provide the vibrant local scientific research community with more efficient access to the latest NEB products, technical support in the local time zone and languages, as well as OEM partnership opportunities," says Sue Yap, General Manager for the Singapore office.
Singapore, recently cited by Scientific American as the world's third most innovative country in biotech, is home to more than 5,000 life science researchers, numerous start-ups, and facilities for many of the largest pharmaceutical companies. Its significance to the biological sciences was reflected this past January, when the country hosted the inaugural Global Young Scientists Summit, featuring 12 Nobel Prize Laureates. Among these was the Chief Scientific Officer of NEB, Sir Richard Roberts, who conducted a seminar to inaugurate the opening of the NEB office.
"Singapore has a world class reputation in the life sciences. This new office will allow us to offer even greater personalized service and, when appropriate, to explore higher levels of collaboration, especially with the startup biotech companies now multiplying in Singapore," says Roberts.
NEB also maintains subsidiary offices in Canada, China, France, Germany, Japan, and the United Kingdom.
For more information, send e-mail to email@example.com or telephone +65 67760903.
About New England Biolabs
Established in the mid 1970's, New England Biolabs, Inc. is the industry leader in the discovery and production of enzymes for molecular biology applications and now offers the largest selection of recombinant and native enzymes for genomic research. NEB continues to expand its product offerings into areas related to PCR, gene expression, library preparation for next generation sequencing, cellular analysis, epigenetics and RNA analysis. Additionally, NEB is focused on strengthening alliances that enable new technologies to reach key market sectors. New England Biolabs is a privately held company, headquartered in Ipswich, MA, and has extensive worldwide distribution through a network of exclusive distributors, agents and seven subsidiaries located in Canada, China, France, Germany, Japan, Singapore and the UK. For more information about New England Biolabs visit www.neb.com.
SOURCE New England Biolabs